Zerit (Stavudine) - Adverse Event Reports - Other Serious Reactions - Abdominal Pain

Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-25

Patient: female, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Flatulence, Mucous Stools, Platelet Count Increased, Hypercholesterolaemia, Hepatomegaly, Malaise, Obesity, Abdominal Distension, Hypertriglyceridaemia, Oxygen Saturation Decreased, Anaemia, Ventricular Tachycardia, Hypotonia, Neutropenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx
    Dosage: received from conception to day 3 of gestation, then from week 27 of gestation to delivery

Zerit

Sustiva

Invirase
    Dosage: initiated at 27 weeks of gestation
    Indication: HIV Infection

Norvir
    Dosage: received from week 27 of gestation to delivery

Fortovase
    Dosage: received from week 27 of gestation to delivery

Viramune
    Dosage: received one single oral dose, from 27 weeks gestation transplacental exposure
    Administration route: Oral
    Indication: HIV Infection

Viramune
    Dosage: received infusion during delivery,

Retrovir
    Dosage: received 6 weeks of antiretroviral therapy after delivery, 200mg/20ml

Retrovir
    Dosage: received from conception to day 3 of gestation and from week 27 of gestation to and at delivery.

Other drugs received by patient: Cordarone; Speciafoldine; Ferrostrane; Uvesterol D; Fluorex; AZT

Adverse event in 38 year old male receiving Zerit (Stavudine)

Reported by a physician from United States on 2007-05-18

Patient: 38 year old male

Adverse reactions / side effects: Abdominal Pain, Immune Reconstitution Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Prezista
    Administration route: Oral
    Indication: HIV Infection

Mk0518
    Administration route: Oral
    Indication: HIV Infection

Ritonavir
    Indication: HIV Infection

Ziagen
    Indication: HIV Infection

Truvada
    Indication: HIV Infection

Zerit
    Indication: HIV Infection

Other drugs received by patient: Valcyte; Bactrim DS; Zyvox

Adverse event in 46 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-03-05

Patient: 46 year old male

Adverse reactions / side effects: Back Pain, Abdominal Pain, Vomiting, Lymphadenopathy, Nausea, Musculoskeletal Pain, Abasia, Muscular Weakness, Hypoaesthesia, Renal Impairment, Malaise, Fatigue, Diarrhoea, Anorexia, Lipoatrophy, Decreased Appetite

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Administration route: Oral
    Indication: HIV Infection CDC Group IV Subgroup C1
    Start date: 1997-08-04
    End date: 2006-05-10

Epivir
    Dosage: restarted on 16-feb-2004 to 10-may-2006.
    Administration route: Oral
    Indication: HIV Infection CDC Group IV Subgroup C1
    Start date: 1997-03-31
    End date: 2000-02-17

Crixivan
    Administration route: Oral
    Indication: HIV Infection CDC Group IV Subgroup C1
    Start date: 1997-08-04
    End date: 1997-09-18

Crixivan
    Administration route: Oral
    Start date: 1997-09-21
    End date: 1999-01-28

Other drugs received by patient: Stadol; Prochlorperazine; Voltaren; Buprenorphine HCL; Magnesium Sulfate; Vitamins; Zovirax; Diflucan; Baktar; Videx; Fungizone; Retrovir; Hivid; Solita-T NO. 3; Buscopan; Folic Acid; Resplen; Clarithromycin; Viracept; Invirase; Norvir; Ziagen; Neurotropin; Hyaluronic Acid; Bendrofluazide; CO-Dydramol; Stocrin; Xylocaine; Amicaliq; Viramune

Adverse event in 44 year old female receiving Zerit (Stavudine)

Reported by a physician from France on 2007-02-28

Patient: 44 year old female, weighing 63.0 kg (138.6 pounds)

Adverse reactions / side effects: Abdominal Pain, Intestinal Ischaemia, Hyperkalaemia, Lipids Increased, Ascites, Drug Toxicity, Antinuclear Antibody Positive, Renal Failure, Blood Amylase Increased, Haemolytic Anaemia, Haemolytic Uraemic Syndrome, Angiopathy, Microangiopathy, Thrombocytopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Intron A
    Dosage: see image
    Indication: Kaposi's Sarcoma
    Start date: 2003-02-14
    End date: 2003-02-17

Intron A
    Dosage: see image
    Indication: Kaposi's Sarcoma
    Start date: 2003-02-14
    End date: 2003-02-24

Intron A
    Dosage: see image
    Indication: Kaposi's Sarcoma
    Start date: 2003-02-17
    End date: 2003-02-24

Trizivir
    Indication: HIV Infection
    Start date: 2003-01-10
    End date: 2003-02-18

Epivir
    Dosage: ; po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-02-20
    End date: 2003-02-24

Zerit
    Dosage: 40 mg; bid; po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-02-20
    End date: 2003-02-24

Ziagen
    Dosage: ; po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-02-20
    End date: 2003-02-24

Noroxin
    Dosage: ; po
    Administration route: Oral
    Indication: Haemolytic Uraemic Syndrome
    Start date: 2003-02-17
    End date: 2003-02-24

Other drugs received by patient: Opiate and Opioid Analgesic (Nos)